Skip to main content
Advanced Technical In the Industry Vocabulary Test

cerebral amyloid angiopathy

Also written as: CAA

Deposition of amyloid protein in brain blood vessel walls, associated with hemorrhage and cognitive decline.

Full Definition

Cerebral amyloid angiopathy (CAA) is a condition characterized by the accumulation of amyloid-beta protein in the walls of cerebral and leptomeningeal arteries, arterioles, and occasionally capillaries. This deposition weakens vessel walls, predisposing to spontaneous intracerebral hemorrhage, particularly in lobar locations. CAA is commonly associated with Alzheimer disease but can occur independently. The diagnosis is made through Congo red staining showing apple-green birefringence under polarized light, or through amyloid-beta immunohistochemistry. Severe CAA can lead to microinfarcts, white matter changes, and cognitive impairment even without major hemorrhages.

Usage

Usage note: Commonly abbreviated as CAA in pathology reports.

In Context

  • "Severe cerebral amyloid angiopathy was identified as the likely cause of the lobar hemorrhage." — Hemorrhagic stroke case report
  • "Congo red staining confirmed extensive cerebral amyloid angiopathy in cortical vessels." — Alzheimer disease autopsy findings

Also known as

CAA amyloid angiopathy

Don't confuse with

atherosclerosis arteriolosclerosis

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON